Prime Medicine, Inc. (PRME) Shareholders’ equity 2020–2025
Prime Medicine, Inc. (PRME) shareholders’ equity at each fiscal year-end, per SEC filings.
$120.9MFY2025 · since FY2020: $2.3M → $120.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $120.9M | -21.1% |
| FY2024 | $153.1M | +15.1% |
| FY2023 | $133.1M | -57.9% |
| FY2022 | $316.3M | +302.4% |
| FY2021 | -$156.2M | -6782.6% |
| FY2020 | $2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice